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Abstract
Due to its similarity to humans, the pig is increasingly being considered as a good
animal model for studying a range of human diseases. Despite their physiological
similarities, differential expression of the myosin heavy chain (MyHC) IIB gene
(MYH4) exists in the skeletal muscles of these species, which is associated with a
different muscle phenotype. The expression of different MyHC isoforms is a critical
determinant of the contractile and metabolic characteristics of the muscle fibre. We
aimed to elucidate whether a genomic mechanism was responsible for the
drastically different expression of MYH4 between pigs and humans, thus improving
our understanding of the pig as a model for human skeletal muscle research. We
utilized approximately 1 kb of the MYH4 promoter from a domestic pig and a human
(which do and do not express MYH4, respectively) to elucidate the role of the
promoter sequence in regulating the high expression of MYH4 in porcine skeletal
muscle. We identified a 3 bp genomic difference within the proximal CArG and E-
box region of the MYH4 promoter of pigs and humans that dictates the differential
activity of these promoters during myogenesis. Subtle species-specific genomic
differences within the CArG-box region caused differential protein-DNA interactions
at this site and is likely accountable for the differential MYH4 promoter activity
between pigs and humans. We propose that the genomic differences identified
herein explain the differential activity of the MYH4 promoter of pigs and humans,
which may contribute to the differential expression patterns displayed in these
otherwise physiologically similar mammals. Further, we report that both the pig and
human MYH4 promoters can be induced by MyoD over-expression, but the
capacity to activate the MYH4 promoter is largely influenced by the 3 bp difference
located within the CArG-box region of the proximal MYH4 promoter.
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Introduction
Skeletal muscle is composed of a heterogeneous population of muscle fibres that
display a broad spectrum of contractile and metabolic characteristics. The
contractile capacity and ATP consumption of a muscle fibre is largely determined
by the isotype of the components that constitute the sarcomere [1]. In particular,
maximal shortening velocity of a muscle fibre is dictated by the predominant
Myosin Heavy Chain (MyHC) isoform expressed [2] and increases in the order of
MyHC I,IIA,IIX,IIB. This crucial role of the MyHC isoform to influence the
contractile performance of the muscle fibre has resulted in significant interest in
understanding the regulation of different MyHC isoforms [3, 4]. Although
regulation of the slower (type I and IIA) MyHC isoforms is relatively well
understood [5, 6, 7, 8], knowledge of the mechanisms regulating the gene
expression of the faster contracting, type IIB MyHC isoform still remains sparse
and incomplete [9, 10].
Despite all mammals carrying the gene (MYH4) encoding MyHC IIB, extensive
characterization has revealed a striking divide between large and small mammals
with regard to MYH4 expression. Most small mammals such as mice [2], rats [2],
rabbits [2, 11], and guinea pigs [12, 13] express MYH4 but most larger mammals
such as cows [14], sheep [15] horses [16], goats [17], cats [18, 19], dogs [20],
baboons [19] and humans [2, 21] do not express. Interestingly, domesticated pigs
remain an anomaly amongst the large mammals as they express high levels of
MYH4 [22, 23], a phenotype likely exacerbated by the intensive selection pressure
for enhanced muscle growth in these animals [24, 25]. This expression of MYH4
in pig skeletal muscle is associated with a dramatically faster and more glycolytic
muscle phenotype compared to that of human skeletal muscle. Given the impact
of MyHC isoform expression on the contractile and metabolic characteristics of
the muscle fibre, it is interesting to explore the mechanisms dictating this
unusually high expression of MYH4 in pig skeletal muscle, which currently
remains unknown.
Previous studies on the MYH4 promoter have elucidated several key regions of
regulatory control (mAT 1/2/3, CArG-box and Ebox) but have predominantly
been conducted on the mouse promoter sequence (a MYH4 expressing species)
[26, 27, 28, 29, 30, 31]. A recent study [32] extended this work to compare the
activity of the human and mouse MYH4 promoter and revealed that a single base
pair mismatch in the human CArG-box sequence (274 bp relative to the TATA-
box) results in reduced MYH4 promoter activity, relative to the equivalent mouse
promoter.
Differences in the regulation of MYH4 expression between rodent species and
humans might be expected as their muscle metabolism, and therefore their
contractility characteristics, are different, probably reflecting the metabolic
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constraints caused by body size [33]. Pigs, on the other hand, are physiologically
similar to humans and are increasingly being considered as a good animal model
for studying a range of human diseases [34]. It is therefore important to
determine what differences exist between these species in order to have confidence
in the use of pigs as a model. Given that pigs also exhibit high expression of
MYH4, unlike humans and most large animals, we set out to determine whether
the mechanisms by which this is achieved is also through variations in promoter
sequence, as is the case in mice when compared to humans [32]. We hypothesized
that genomic differences in the MYH4 promoter of pigs and humans dictate the
differential expression of MYH4, which is associated with a different muscle
phenotype in these otherwise physiologically similar mammals. Using an in vitro
fluorescence based promoter-reporter system; we utilized approximately 1 kb of
the MYH4 promoter from a domestic pig and a human to elucidate the role of the
promoter sequence in regulating the high expression of MYH4 in porcine skeletal
muscle.
Materials and Methods
Cloning
Approximately 1 kb of the pig and human MYH4 promoters (2961 bp to
+32 bp, relative to the TATA box) was generated by polymerase chain reaction
(PCR) and cloned into the pZsGreenI-I fluorescence-reporter plasmid (Clontech)
for transfection studies in the C2C12 mouse myoblast cell line. All base pair
numbering is relative to the TATA-box, as a discrepancy existed as to the location
of the transcription start site between the two promoters. Accession numbers for
the pig and human MYH4 gene (NM_001123141.1 and ENSG00000264424.1,
respectively) were used to locate the first exon and the 39 oligonucleotide primer
was designed to span into the first exon to ensure inclusion of the transcription
start site. All oligonucleotide sequences are displayed in Table 1.
Pig and human MYH4 promoters were subjected to 59 deletion analysis
creating promoters of varying lengths (2961 bp, 2466 bp, 2231 bp, 2113 bp,
267 bp; promoter lengths are relative to the TATA-box). Site directed
mutagenesis and site-specific deletions within the MYH4 promoters were
introduced by PCR (specific base pair substitutions are described in the results
section).
Chimeric MYH4 promoters (containing combinations of both distal and
proximal regions of the pig and human MYH4 promoters) were produced
according to a design previously demonstrated [32]. A HindIII restriction site
(2 bp mutation; at 2218 bp and 2217 bp) was introduced to both the pig and
human 1 kb promoter allowing the proximal promoter regions to be swapped by
restriction digest, generating chimeric promoters. Proximal promoter regions
were also swapped with a minimal CMV promoter (84 bp) to test for potential
regulatory regions in the 59 distal region (,750 bp) of each promoter,
independent of the proximal promoter.
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Full-length open reading frame MyoD cDNA (accession number:
ENSMUST00000072514.1) was generated by RT-PCR, cloned into the pDsRed-
Express-N1 plasmid (clontech) and over-expressed in C2C12 cells under the
control of a CMV promoter. A pDsRed-Express-N1 plasmid lacking the CMV
promoter was used as a vehicle transfection control.
Table 1. Oligonucleotide sequences used for cloning. Bold underline indicates base pairs being mutated.
Oligonucleotide name Sequence (59-39)
Human_MYH4_R AAAAAACCCGGGAGGAAGGATGGGAAAGAGG
Pig_ MYH4_R AAAAAACCCGGGAGGAAGGACAGGACAGAGGCAT
Human_ MYH4_67bp_F AAAAAACTCGAGGCCAAGTAGGTTCCCAGCTAG
Pig_ MYH4_67bp_F AAAAAACTCGAGGCCAAGTAGGTTCCCAGCTGG
Human+pig_ MYH4_113bp_F AAAAAACTCGAGCCACAGTCAGTGAATATTGTGCA
Human_ MYH4_231bp_F AAAAAACTCGAGCAGTGTTAGAAGCCCTGAATCC
Pig_ MYH4_231bp_F AAAAAACTCGAGTAGCCTTAGAAGCCCTGAATCTC
Human_ MYH4_466bp_F AAAAAACTCGAGTCCAGACTGTGGCTAGGAATG
Pig_ MYH4_466bp_F AAAAAACTCGAGTCATCAGTATTTCTAAAATCCAGACC
Pig_961bp_(1kb)_ MYH4_F AAAAAACTCGAGTAGGTGACACACTTAGCGTGGACA
Human_961bp_(1kb)_ MYH4_F AAAAAACTCGAGCTTAGAGTAGGTATATTTCCTGCCAT
Human_ MYH4_HindIII_F CAGTGTTAGAAGCTTTGAATCCCCATC
Human_ MYH4_HindIII_R TTTCTCCAGTTTGGCTGTTGCATC
Pig_ MYH4_HindIII_F GCCTTAGAAGCTTTGAATCTCCATC
Pig_ MYH4_HindIII_R TATTTCTCCAGCTTTGCTGTTCCATC
Human_ MYH4_AT3_SDM_F CTATCAAATGCCTCAAAAGAACCCTAGA
Human_ MYH4_AT3_SDM_R GGGATGGGGATTCAGGGC
Human_ MYH4_midAT2-3_SDM_F GAACCCTAGATGATCCTCTGTTAAAT
Human_ MYH4_midAT2-3_SDM_R TTTATAGGCATTTGATAGGGGATGG
Human_ MYH4_distAT2_SDM_F CTAGATCATCCTCTGTCAAATTATTTATGGG
Human_ MYH4_distAT2_SDM_R GGTTCTTTATAGGCATTTGATAGGGG
Human_ MYH4_proxAT2_SDM_F CCTCTGTTAAATTATTTATAGGTGTCAAGAAATA
Human_ MYH4_proxAT2_SDM_R ATGATCTAGGGTTCTTTATAGGCATT
Human_ MYH4_CArG_SDM_F AGATTGCCAAAAAAGGTTTTGCCAAG
Human_ MYH4_CArG_SDM_R CTTTGCACAATATTCACTGACTGTGG
Human_ MYH4_EBOX2_SDM_F TTCCCAGCTGGGACAGCT
Human_ MYH4_EBOX2_SDM_R CCTACTTGGCAAAACCGTTTTTGGC
Human_ MYH4_T_removal_F GCCAAGTAGGTTCCCAGCT
Human_ MYH4_T_removal_R AAACCTTTTTTGGCAATCTCTTTGCAC
No-CArG_R CTCTTTGCACAATATTCACTGACTGTG
No-CArG_Pig_ MYH4_F AGTAGGTTCCCAGCTGGG
No-CArG_Human_ MYH4_F AGTAGGTTCCCAGCTAGGAC
CMV-basic_F AAAAAAAAGCTTGCAAATGGGCGGTAGGC
CMV-basic_R AAAAAACCCGGGGATCTGACGGTTCACTAAACCAGC
MyoD_F AAAAAAAGATCTGCCACCATGGAGCTTCTATCGCCG
MyoD_R AAAAAAACCGGTGCTCAAAGCACCTGATAAATCGC
doi:10.1371/journal.pone.0114365.t001
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Electrophoretic mobility shift assay
Protein-DNA interactions were assessed by incubating C2C12 myotube nuclear
extracts with a 59 biotin labeled double-stranded probe for a 62 bp region
spanning (and inclusive of) the CArG-box and Ebox2 sequence (293 bp to
231 bp relative to the TATA-box) from the pig MYH4 promoter (probe
sequences are in Table 2). Three shorter un-labeled probes, from the same region
(pig sequence), were used to compete for bound proteins and identify the specific
regions within the 62 bp probe interacting with nuclear protein(s). Three
equivalent human un-labeled probes were used to assess whether the species-
specific sequence variation in these regions impaired competition for the proteins
bound to the pig 62 bp labeled probe. Unlabeled competitor probes were designed
to the following regions, CArG-box: 291 bp to 260 bp, mid-probe: 274 bp to
251 bp and E-box2 probe: 263 bp to 231 bp, all relative to the pig TATA-box.
Protein-DNA binding conditions consisted of 50 ng/ul Poly dI-dC, 5%
glycerol, 0.05% NP-40, 50 mM KCL, 1 mM MgCl2, 1 mM EDTA, 20 fmol biotin-
labeled probe, 4 pmol un-labeled competitor probe and 3 ml of C2C12 myotube
nuclear extract (from NE-PER extraction kit, Thermo Scientific) in 1x binding
buffer (LightShift Chemiluminescent EMSA kit, Thermo Scientific) in a total
volume of 20 ml. Protein-DNA binding reactions were incubated at room
temperature for 20 minutes, separated by electrophoresis on a 6% non-denaturing
polyacrylamide gel (Invitrogen, Novex) at 100 V for 75 minutes and transferred
by electro-blotting to a Biodyne-B nylon membrane (Thermo Scientific) at 100 V
for 45 minutes. Protein-DNA complexes were cross-linked for 60 seconds (auto-
crosslink) and biotin-labeled probes were detected using the LightShift
Chemiluminescent EMSA detection module (Thermo Scientific) according to the
manufacturer’s instructions.
Cell culture and transfections
C2C12 mouse myoblasts were cultured in proliferation medium (DMEM, 10%
fetal bovine serum, 1% penicillin and streptomycin) and induced to differentiate
at confluence by switching to differentiation medium (DMEM, 2% horse serum,
1% penicillin and streptomycin) for up to 6 days. Medium was refreshed every
48 hours.
Myoblasts (at ,70% confluence) were transfected with the pig or human 1 kb
MYH4 pZsGreenI-I promoter-reporter plasmid using FugeneHD (Promega)
transfection reagent at a ratio of 3:1 (FugeneHD:DNA). Each well was co-
transfected with pDsRed-Express-N1 as a transfection efficiency control for
normalizing ZsGreenI-I promoter-reporter fluorescence. MYH4 promoter
activities (fluorescence output) were quantified following 5 or 6 days of
differentiation using the Typhoon Trio+ (GE healthcare). MyoD over-expression
plasmids (or pDsRed-Express-N1 plasmids lacking the CMV promoter) were
transfected into myoblasts at the same time as the MYH4 promoter-reporter
plasmids at a ratio of 1:1.
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Statistical analysis
All fluorescence promoter-reporter assays were conducted using 4 biological
replicates (wells). Data is displayed as mean¡ standard deviation (SD). Statistical
analysis was conducted using GenStat (version 15) and significance was accepted
at p,0.05.
Results
Alignment of the pig and human MYH4 promoter sequences revealed very high
similarity (1 kb580% identical; proximal 200 bp595% identical). Following
transfection into mouse C2C12 muscle cells, activity of the 1 kb pig and human
MYH4 promoters was restricted to differentiated myotubes (indicated by ZsGreen
fluorescence), unlike a CMV-driven ZsGreen control, which was expressed in
myoblasts and myotubes; see Figure 1A). Despite both promoters being active in
differentiated C2C12 myotubes, the 1 kb pig MYH4 promoter had higher activity
than the equivalent human promoter, which was only mildly active (Figure 1A
Table 2. Probe sequences used for electrophoretic mobility shift assays.
EMSA probe name EMSA probe sequence (59 to 39)
Pig_ MYH4_probe_sense
(biotin-labelled)
TGCAAAGAGATTGCCAAAAAAGGTTTGCCAAGTAGGTTCCCAGCT-
GGGACAGCTGAGGTGGC
Pig_ MYH4_probe_anti-sense
(biotin-labelled)
GCCACCTCAGCTGTCCCAGCTGGGAACCTACTTGGCAAACCTTTT-
TTGGCAATCTCTTTGCA
Human_ MYH4_CArG-competi-
tor_sense
AAGAGATTGCCAAAAACGGTTTTGCCAAGT
Human_ MYH4_CArG-competi-
tor_anti-sense
ACTTGGCAAAACCGTTTTTGGCAATCTCTT
Human_ MYH4_mid-probe-com-
petitor_sense
CGGTTTTGCCAAGTAGGTTCCCA
Human_ MYH4_mid-probe-com-
petitor_anti-sense
TGGGAACCTACTTGGCAAAACCG
Human_ MYH4_E-box2-compe-
titor_sense
AGTAGGTTCCCAGCTAGGACAGCTGAGGTGGC
Human_ MYH4_E-box2-compe-
titor_anti-sense
GCCACCTCAGCTGTCCTAGCTGGGAACCTACT
Pig_ MYH4_CArG-competitor_-
sense
AAGAGATTGCCAAAAAAGGTTTGCCAAGT
Pig_ MYH4_CArG-competitor_-
anti-sense
ACTTGGCAAACCTTTTTTGGCAATCTCTT
Pig_ MYH4_mid-probe-competi-
tor_sense
AGGTTTGCCAAGTAGGTTCCCA
Pig_ MYH4_mid-probe-competi-
tor_anti-sense
TGGGAACCTACTTGGCAAACCT
Pig_ MYH4_E-box2-competitor_-
sense
AGTAGGTTCCCAGCTGGGACAGCTGAGGTGGC
Pig_ MYH4_E-box2-competitor_-
anti-sense
GCCACCTCAGCTGTCCCAGCTGGGAACCTACT
doi:10.1371/journal.pone.0114365.t002
Regulation of the Porcine Myosin Heavy Chain IIB Gene
PLOS ONE | DOI:10.1371/journal.pone.0114365 December 3, 2014 6 / 17
and 1B; p50.006). Due to the disparity in MYH4 promoter induction during
myogenesis, we asked whether MyoD, a myogenic regulatory factor known to
induce MYH4 expression [10, 29, 30, 32], was activating the pig, but not human
MYH4 promoter during C2C12 myogenesis. Over-expression of mouse MyoD
during C2C12 differentiation was capable of inducing both the pig and human
MYH4 promoters by ,3 and ,4-fold respectively (Figure 2A; p,0.01).
Fluorescence microscopy revealed that MYH4 promoter activity was still restricted
to differentiated myotubes in the presence of MyoD over-expression (data not
shown). Although both the pig and human MYH4 promoters were induced by a
myogenic signal (MyoD), the absolute capacity for induction of the human
MYH4 promoter was significantly restricted in comparison to the pig MYH4
promoter activity. It was therefore postulated that response elements within the
human MYH4 promoter were limiting the capacity to fully activate the promoter
and that the pig MYH4 promoter contained response elements that permitted a
much greater potential for activation during myogenic differentiation.
Figure 1. Pig and human MYH4 promoter activities in C2C12 muscle cells. (A) Representative fluorescence images show 1 kb MYH4 promoter-reporter
constructs are differentiation specific. (B) Equivalent 59 deletion analysis of the pig and human MYH4 promoters. Promoter activities in Day 6 differentiated
C2C12 myotubes (mean ¡ SD). * Indicates Human MYH4 promoter activity was significantly different to the equivalent length pig promoter (p,0.05). (C)
1 kb pig and human MYH4 promoter activity in response to (mouse) MyoD over expression in day 5 differentiated C2C12 myotubes (mean ¡ SD). *
Indicates MYH4 promoter activity was significantly different to the control transfection (p,0.05).
doi:10.1371/journal.pone.0114365.g001
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In order to locate regulatory regions controlling the differential activity of the
pig and human 1 kb MYH4 promoters, we conducted equivalent 59 deletion
analysis of both promoters. Disparity in pig and human MYH4 promoter activity
persisted with decreasing promoter length (from 2961 bp to 2113 bp) and
declined similarly for promoters from both species (Figure 1B). Removal (by 59
deletion) of ,120 bp, between 2231 bp to 2113 bp, essentially removing the
AT-rich regions (AT 1, 2 and 3), caused the largest reduction in promoter activity
for both the pig and human MYH4 promoters (84% and 82% respectively).
Deletions at the 59 end of the pig and human MYH4 promoters from 2961 bp to
2466 bp caused a 26% and 37% reduction, respectively, and deletion from
2466 bp to 2231 bp caused a 50% and 58% reduction, respectively. The largest
disparity in promoter activity between the pig and human MYH4 promoters
existed in the 2231 bp promoters (,5-fold difference; p,0.001), indicating that
response elements controlling high and low MYH4 promoter activity likely
resided downstream of 2231 bp.
To confirm the role of the proximal promoter sequence in dictating high and
low MYH4 promoter activity, we produced chimeric MYH4 promoters (generated
by swapping the proximal region (2218 bp to +32 bp) of the pig and human
promoters). When the proximal region of the pig 1 kb MYH4 promoter was
replaced with the equivalent human proximal promoter, activity was reduced
(p,0.001) to the same level as the human 1 kb MYH4 promoter (Figure 2A;
p50.627). When the proximal region of the human 1 kb MYH4 promoter was
replaced by the equivalent pig proximal promoter, activity was increased
Figure 2. Pig and Human chimeric MYH4 promoter activities in C2C12 muscle cells. (A) Pig-human and human-pig (59 to 39) chimeric MYH4 promoters
were constructed to assess the role of the proximal 250 bp of each promoter within the context of a 1 kb promoter. (B) The distal (,750 bp) of the pig and
human MYH4 promoters were cloned upstream of a minimal CMV promoter (84 bp) to assess whether this region elicits enhancer activity independent of
the proximal (,250 bp) MYH4 promoter (mean ¡ SD). Differing letters (a,b,c) constitute a significant difference between promoter activities (p,0.05).
doi:10.1371/journal.pone.0114365.g002
Regulation of the Porcine Myosin Heavy Chain IIB Gene
PLOS ONE | DOI:10.1371/journal.pone.0114365 December 3, 2014 8 / 17
(p,0.001) and interestingly exhibited an almost 2-fold greater activity than the
1 kb pig MYH4 promoter (p50.005). The chimeric promoters confirmed that
sequence differences in the proximal promoter regions (totaling 14 bp
differences) dictate the high and low MYH4 promoter activities. For complete-
ness, the pig and human proximal MYH4 promoters (2218 bp to +32 bp) were
replaced by an 84 bp minimal CMV promoter, which revealed that, the 59 distal
human (p,0.001), but not pig (p50.135), MYH4 promoter region was capable of
increasing the basal promoter activity of the minimal CMV promoter (Figure 2B).
This highlights that the proximal MYH4 promoter region contains the key
response elements required to elicit differential promoter activities between pigs
and humans. To identify the specific sequence differences responsible for the
differential pig and human MYH4 promoter activities, we analyzed the effects of
site directed mutagenesis on promoter activities in C2C12 myotubes. Site directed
mutagenesis within the AT rich regions (mAT2 and mAT3) of the human 1kb
MYH4 promoter (making base pair alterations to match the equivalent pig
promoter), had no impact on MYH4 promoter activity (Figure 3A). However, a
single base pair alteration within the human CArG-box (at 274 bp), was
sufficient to increase promoter activity by ,2.5-fold (p50.001), but promoter
activity remained lower than the 1 kb pig MYH4 promoter (p50.007; Figure 3A).
Further site directed mutagenesis downstream of the CArG-box in the human
MYH4 promoter highlighted a group of 3 bp mutations required to increase
promoter activity to the same level as the pig MYH4 promoter (Figure 3B). A
single base pair mutation within the human CArG-box sequence (at 274 bp)
increased promoter activity (p,0.001) but remained lower than the activity of the
1 kb pig MYH4 promoter (p,0.001). Removal of a single nucleotide (at 268 bp)
from the human MYH4 CArG-box mutant promoter resulted in a further increase
in promoter activity, compared to the CArG-box mutant promoter (p,0.001),
but this level of activity still remained lower than the 1 kb pig MYH4 promoter
(p50.023). Finally, a combination of the CArG-box mutation (at 274 bp), with
the removal of a single nucleotide (at 268 bp), and a single base pair change in
the E-box2 (at 248 bp) caused an increase in human MYH4 promoter activity
(p,0.001) to a level equal to the 1 kb pig MYH4 promoter (p50.895).
Electrophoretic mobility shift assays were conducted to determine whether the
3 bp mismatch, responsible for the disparity in promoter activity between the pig
and human MYH4 promoters, caused differential nuclear protein binding to this
region (Figure 4A). Two protein-DNA complexes (labeled A and B) formed with
the pig 62 bp probe (spanning and inclusive of the CArG-box and Ebox2 (293 bp
to 231 bp)). To identify specific regions of the 62 bp probe bound by protein(s),
200-fold molar excess of shorter, un-labeled competitor probes were included in
the binding reactions. The un-labeled pig CArG-box probe (29 bp in length)
bound the proteins forming both complexes A and B with the 62 bp pig probe, as
both bands were lost/reduced (Figure 4A). The un-labeled pig mid-probe and
Ebox2 probes, however, were unable to compete for proteins bound to the 62 bp
probe, as there were no effects on either band. Interestingly, proteins bound to the
pig CArG-box region were sensitive to the species-specific differences at 274 bp
Regulation of the Porcine Myosin Heavy Chain IIB Gene
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and 268 bp in the pig and human CArG-box region (2 bp mismatch). The un-
labeled human CArG-box competitor probe was capable of competing with the
pig 62 bp probe for proteins forming complex A, but not B. Like the equivalent
pig competitor probes, the human mid-probe and Ebox2 probes were also unable
to compete for proteins bound to the 62 bp pig probe. Therefore, the 2 bp
mismatch at 274 bp and 268 bp in the pig and human CArG-box region
resulted in differential protein-DNA interactions, highlighting the functional
importance of sequence variation in this genomic region.
Finally, to confirm the role of sequence variation at 274 bp and 268 bp in the
CArG-box region to dictate the strength of porcine MYH4 promoter induction,
the CArG-box region (263 bp to 284 bp; inclusive of the two mismatches at
274 bp and 268 bp) was deleted from the pig 1 kb MYH4 promoter, which
reduced activity (p,0.001; Figure 4B) to the same level as the 1 kb human MYH4
promoter (p50.134). Despite sequence differences in this region, removal of the
equivalent CArG-box region from the 1 kb human MYH4 promoter also
moderately reduced promoter activity (p,0.001; Figure 4B).
Figure 3. Mutated human MYH4 promoter activity in C2C12 muscle cells. (A) Site directed mutagenesis within the AT-rich region and the CArG-box of
the 1 kb human MYH4 promoter (substitutions indicated by a ‘‘bolt’’ symbol). (B) Site directed mutagenesis within the CArG/Ebox2 region of the 1 kb human
MYH4 promoter. A ‘‘bolt’’ indicates a single base pair substitution and a ‘‘cross’’ indicates removal of a single base pair. Promoter activities were measured in
day 6 differentiated C2C12 myotubes (mean ¡ SD). Differing letters (a,b,c,d,e) constitute a significant difference between promoter activities (p,0.05).
Open bar 5 pig promoter; black bar 5 human promoter; grey bar 5 mutant human promoter.
doi:10.1371/journal.pone.0114365.g003
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An alignment of the proximal pig and human MYH4 promoter (Figure 5A)
highlighted the close proximity of the 3 bp mismatches in the CArG and E-box
region that are responsible for the high level activity of the porcine MYH4
promoter. An additional alignment of this CArG and E-box region from multiple
MYH4 expressing and non-expressing species (Figure 5B) identified that there is
Figure 4. The role of the CArG-box promoter response element in pig and human MYH4 promoter activity. (A) Electrophoretic mobility shift assay
using a 62 bp biotin labeled probe (spanning the pig CArG and Ebox2 region; 291 bp to 231 bp relative to the TATA-box). Probes were incubated with
C2C12 myotube nuclear extracts. Cross-species competition for bound proteins was conducted using shorter un-labeled pig and human probes. The human
CArG-box is unable to bind proteins forming complex B with the pig CArG-box. Experiments were repeated 3 times to confirm the results. (B) Removal of the
CArG-box region (total of 22 bp removed) from the 1 kb pig and human MYH4 promoters. Promoter activities were measured in day 6 differentiated C2C12
myotubes (mean ¡ SD). Differing letters (a,b,c) constitute a significant difference between promoter activities (p,0.05).
doi:10.1371/journal.pone.0114365.g004
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no common variation in sequence that is responsible for the differential
expression of MYH4, but sequence variation within this region does exist between
species.
Discussion
Myosin heavy chain (MyHC) isoform expression is a key determinant of the
contractile performance of the muscle fibre, with maximal shortening velocity
increasing in the order of MyHC I,IIA,IIX,IIB [2]. Mechanisms regulating the
expression of the different MyHC isoforms in skeletal muscle have therefore been
Figure 5. Comparison of the evolutionary conserved CArG-box and E-box region in MYH4 expressing and non-expressing species. (A) Alignment
of the proximal pig and human MYH4 promoter. All base pair numbering is relative to the respective TATA-box (+1). Base pair mismatches, highlighted in
black (with base pair numbering relative to the human TATA-box), were responsible for the differential activity of the 1 kb pig and human MYH4 promoter in
C2C12 myotubes. Bold-underline indicates the 62 bp pig probe used in EMSA experiments (spanning the CArG-box and E-box region (293 bp to231 bp)).
The two bold base pairs (CC) indicate the mutated HindIII site for generating chimeric-promoters. (B) Cross-species alignment of the CArG-box and E-box
region from MYH4 expressing and non-expressing animals. Bases highlighted in the black columns indicate the location of crucial base pair differences
required for high MYH4 expression in pigs relative to humans. There is no common mutation amongst MYH4 expressing and non-expressing species, but
there are a number of differences (highlighted in grey) within this highly conserved region, which may be critical to the strength of promoter activation.
doi:10.1371/journal.pone.0114365.g005
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of significant interest within the scientific community [3, 4]. Interestingly,
extensive characterization has revealed a species differential expression of the
fastest contracting isoform, MYH4, which is associated with different muscle
phenotypes between species. Of particular interest, domestic pigs express very
high levels of MYH4 [22, 24, 25], unlike most large mammals (which do not
normally express MYH4), and exhibit a faster and more glycolytic muscle
phenotype in comparison. We examined the role of the MYH4 promoter sequence
in dictating the expression of MYH4 in pigs, compared to humans, which do not
express MYH4 [2, 21]. Due to its similarity to humans, the pig is increasingly
being considered as an animal model for a range of human diseases [34] and it is
therefore useful to understand the mechanisms responsible for the physiological
differences between these species. We identify a genomic difference within the
MYH4 promoter of pigs and humans that dictate differential promoter activity
during myogenesis and postulate that these genomic differences partly explain the
different MYH4 expression profiles in these otherwise physiologically similar
mammals.
We previously reported that the C2C12 cell line is a dynamic MYH4 expressing
environment, with mRNA expression increasing throughout the latter stages of
myogenic differentiation [35]. This cell line was selected for transfection studies of
the pig and human MYH4 promoter-reporter constructs, providing a common
and non-biased MYH4 inducing environment for testing both promoters. In this
environment, 1 kb of the pig MYH4 promoter elicited very strong activity that is
consistent with the very high level of endogenous MYH4 expression observed in
pigs [22, 23]. In contrast, the human 1 kb MYH4 promoter was only mildly active
during C2C12 myogenic differentiation. We were slightly surprised by the extent
of the human MYH4 promoter activity in C2C12 cells given that humans do not
normally express MYH4 transcripts in vivo [2, 21], suggesting that this promoter
can display mild activity given the appropriate environment. In support of this,
Harrison et al. [32] previously reported expression of the MYH4 transcript in
cultured human fetal primary myotubes, but not in adult human muscle biopsy
samples, suggesting that the human MYH4 promoter may only be active during
myogenesis. Despite being active during C2C12 myogenesis, the human MYH4
promoter activity remains blunted in comparison to equivalent promoters from
MYH4 expressing species, such as pigs (data presented herein) or mice [32].
Taken together, this suggests that the MYH4 promoter sequence plays a critical
role in dictating the strength of MYH4 promoter induction during myogenesis
and that this disparity in promoter activity can occur independent of nerve
innervation in muscle cells. Furthermore, we also show that although both the pig
and human MYH4 promoters are responsive to a known MYH4 inducing
stimulus, such as MyoD over-expression [10, 30, 32], the absolute capacity to
activate the human MYH4 promoter was limited in comparison to the equivalent
pig promoter, suggesting that sequence differences between the two promoters
dictate the capacity for induction during myogenesis.
We proceeded to elucidate the specific genomic sequence variation responsible
for the differential MYH4 promoter activities during myogenesis. Surprisingly, a
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cluster of just 3 bp mismatches in the proximal CArG and Ebox region (at
274 bp,268 bp and248 bp) was responsible for the disparity in pig and human
MYH4 promoter activities during myogenesis. The nucleotide mismatch at
274 bp was located in the AT-rich region of a proximal CArG-box (consensus
sequence: CC(A/T)6GG), resulting in the human CArG-box being a non-
consensus CArG-box (CCAAAAAcGG), unlike the equivalent consensus CArG-
box in the pig MYH4 promoter (CCAAAAAaGG). This single bp difference was
partly responsible for the differential pig and human MYH4 promoter activities
during myogenesis. Available literature suggests the CArG-box is a response
element that is typically (but probably not exclusively) bound by serum response
factor (SRF) and is instrumental for activating many muscle specific genes,
particularly genes encoding contractile and structural components of muscle
[36, 37]. By deleting the CArG-box and the immediate flanking regions (inclusive
of mismatch sites 274 bp and 268 bp) from the MYH4 promoters, we report a
critical role of this CArG-box region in regulating the strong transcriptional
activation of the porcine MYH4 promoter during myogenesis. Furthermore, by
mutating the species-specific mismatches (274 bp and 268 bp) in the CArG-box
region, we confirm that these subtle sequence variations within the CArG-box
region are crucial to the species-specific strength of MYH4 promoter induction
during myogenesis. This is in agreement with the findings of Harrison et al. [32]
who also report that a single bp mutation in the same location (274 bp) of the
AT rich region of the proximal CArG-box is instrumental in dictating the strong
induction of the mouse MYH4 promoter. Interestingly, we show that the human
non-consensus CArG-box region (inclusive of mismatch sites 274 bp and
268 bp) was still partially functional, as removal of this region was sufficient to
moderately reduce promoter activity.
We demonstrated that sequence variation in, and close to, the CArG-box
response element (at 274 bp and 268 bp) was of functional significance, with
only 1 of the 2 protein-DNA complexes that form with the pig CArG-box region
being capable of forming with the human CArG-box region. Sequence variation
within CArG-boxes has previously been reported to influence promoter trans-
activation by myogenic regulatory factors that bind nearby E-boxes [38] and
presents a potential mechanism underlying the differential promoter activities
displayed herein.
It is also interesting to speculate whether the close proximity of the 3 bp
mismatches identified herein may permit, or restrict, co-operative interactions
between factors binding CArG-boxes and E-boxes, since such factors have been
shown to physically interact and form trimeric heterodimers [37]. Indeed others
have postulated that interactions between CArG and E-boxes may influence
Myosin Light Chain 1A gene promoter activation [38]. We show that the removal
of a single nucleotide at 268 bp, reducing the gap between the CArG-box and the
E-box2, resulted in an increase in promoter activity that, although speculative,
may be facilitated by co-operative binding at these two response elements.
Therefore, we speculate that species-specific differences in the CArG/E-box
region, rather than within a specific response element, are likely crucial to
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facilitate a strong induction of the porcine MYH4 promoter and that the role of
this sequence variation warrants further investigation.
It is important to note that the specific promoter sequence mismatches
identified herein between pigs and human are unlikely to account for the lack of
MYH4 expression in other non-expressing species (see Figure 5B). For example,
the MYH4 promoters of cows and sheep contain a consensus CArG-box sequence
(in the equivalent location) yet still display a lack of MYH4 expression. These
species do however show mismatches (relative to MYH4 expressing species)
within the highly conserved CArG/E-box2 region, supporting our speculation that
sequence variation within this region is possibly a critical mechanism underlying
differential MYH4 promoter activation. The complexities of protein-DNA
interactions between the CArG- and E-box response elements require further
investigation to determine their role in regulating the differences in MYH4 gene
expression across species.
For the first time, we identify a genomic difference within the MYH4 promoter
of pigs and humans that dictate differential promoter activity during myogenesis
and postulate that these genomic differences partly explain the different MYH4
expression profiles in these otherwise physiologically similar mammals. We
therefore extend the work of Harrison et al. [32] and conclude that the sequence
of the CArG-box and its immediate flanking regions, are not only critical for
MYH4 expression in small mammals, but is also a region whereby critical
sequence variation can permit MYH4 expression in large mammals as well. We
also demonstrate that both the pig and human MYH4 promoters are responsive to
stimuli (i.e. MyoD) known to induce MYH4 expression, but the capacity for
induction is severely influenced by the 3 bp genomic difference identified herein.
This work furthers our understanding of genomic mechanisms dictating
expression of the fast contracting MYH4 isoform in mammalian skeletal muscle
cells.
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